Matthew H.G. Katz
University of Texas MD Anderson Cancer Center
CancerInternal medicineRadiologySurgeryPathologyOncologyChemotherapyNeoadjuvant therapyPancreatectomyPancreasPancreaticoduodenectomySurgical oncologyPancreatic cancerGemcitabineAdenocarcinomaCancer researchGeneral surgeryMedicineGastroenterology
401Publications
69H-index
10.3kCitations
Publications 393
Newest
#1Giampaolo Perri (University of Texas MD Anderson Cancer Center)H-Index: 8
#2Matthew H.G. KatzH-Index: 69
Source
Abstract null null Purpose null Patients with pancreatic cancer often receive radiation therapy before undergoing surgical resection. We compared the clinical outcomes differences between stereotactic body radiation therapy (SBRT) and 3-dimensional (3D)/intensity-modulated radiation therapy (IMRT). null null null Methods and Materials null We retrospectively collected data from the University of Texas MD Anderson Cancer Center. Patients with borderline resectable/potentially resectable or locall...
Source
#1Naruhiko Ikoma (University of Texas MD Anderson Cancer Center)H-Index: 16
#2Jeffrey E. Lee (University of Texas MD Anderson Cancer Center)H-Index: 108
Last. Matthew H.G. Katz (University of Texas MD Anderson Cancer Center)H-Index: 69
view all 3 authors...
Source
#1Rebecca A. Snyder (ECU: East Carolina University)H-Index: 13
#2Syed A. Ahmad (UC: University of Cincinnati)H-Index: 58
Last. Matthew H.G. Katz (University of Texas MD Anderson Cancer Center)H-Index: 69
view all 3 authors...
Surgeon-led clinical trials have defined the standard of care for locoregional pancreatic cancer to date. The infrastructure and collaborative nature of cooperative oncology groups offer many advantages, such as providing an ideal mechanism through which multidisciplinary pancreatic cancer trials are performed. As key members of the treatment team, surgeons bring experience and expertise to the design of surgical and multidisciplinary trials and are uniquely poised to be leaders of future pancre...
Source
#1Naruhiko Ikoma (University of Texas MD Anderson Cancer Center)H-Index: 16
#2Michael P. Kim (University of Texas MD Anderson Cancer Center)H-Index: 25
Last. Matthew H.G. Katz (University of Texas MD Anderson Cancer Center)H-Index: 69
view all 10 authors...
Over the past few decades, robotic surgery techniques required to resect gastric and pancreatic malignancies have evolved remarkably; however, the safety and generalizability of robotic pancreatoduodenectomy remain unknown. At our cancer center, gastrectomies and pancreatectomies are performed in a combined foregut minimally-invasive surgery program; this effectively increases the composite case volume and shortens the learning curve for any individual surgeon. In this video, we demonstrate the ...
Source
#5Bingbing Dai (UTSW: University of Texas Southwestern Medical Center)H-Index: 17
#6Matthew H.G. Katz (UTSW: University of Texas Southwestern Medical Center)H-Index: 69
Abstract Pancreatic ductal adenocarcinoma (PDAC) tumors are characterized by a desmoplastic reaction and dense collagen that is known to promote cancer progression. A central mediator of pro-tumorigenic collagen signaling is the receptor tyrosine kinase discoid domain receptor 1 (DDR1). DDR1 is a critical driver of a mesenchymal and invasive cancer cell PDAC phenotype. Previous studies have demonstrated that genetic or pharmacologic inhibition of DDR1 prevents PDAC tumorigenesis and metastasis. ...
Source
#1Natalia Paez Arango (University of Texas MD Anderson Cancer Center)H-Index: 3
#2Laura R. Prakash (University of Texas MD Anderson Cancer Center)H-Index: 15
Last. Ching Wei D. Tzeng (University of Texas MD Anderson Cancer Center)H-Index: 34
view all 10 authors...
Delayed gastric emptying (DGE) is a frequent complication after pancreaticoduodenectomy (PD) that impairs recovery and quality of life. The purpose of this study was to assess the impact risk-stratified pancreatectomy clinical pathways (RSPCPs) had on delayed gastric emptying (DGE) and identify factors associated with DGE in a contemporary period. A single-institution, prospective database was queried for consecutive PDs during July 2011–November 2019. Using international definitions, DGE rates ...
Source
#1Timothy E. NewhookH-Index: 14
#2Timothy J. VreelandH-Index: 11
Last. Michael J. OvermanH-Index: 62
view all 17 authors...
Source
#2Ching Wei Tzeng (University of Texas MD Anderson Cancer Center)H-Index: 7
#3Yi Ju Chiang (University of Texas MD Anderson Cancer Center)H-Index: 19
BACKGROUND Despite the high frequency of regional lymph node (LN) metastases associated with duodenal neuroendocrine tumors (D-NETs), the impact of these metastases on survival and the ideal extent of LN dissection are unknown. We used the National Cancer Database (NCDB) to investigate factors associated with survival, including LN metastases and types of surgery, in patients with D-NETs. METHODS All patients with D-NETs recorded in the NCDB between 2004 and 2016 were included in the study. We a...
Source
#1Timothy E. Newhook (University of Texas MD Anderson Cancer Center)H-Index: 14
#2Laura R. Prakash (University of Texas MD Anderson Cancer Center)H-Index: 15
Last. Jessica E. Maxwell (University of Texas MD Anderson Cancer Center)H-Index: 2
view all 15 authors...
BACKGROUND AND OBJECTIVES The impact of perioperative blood transfusion (PBT) on outcomes for pancreatic ductal adenocarcinoma (PDAC) patients given multimodality therapy (MMT) remains undefined. We sought to evaluate the association of PBT with survival after PDAC resection. METHODS Pancreatectomy patients (July 2011-December 2017) who received MMT were abstracted from a prospective database. Overall survival (OS) was compared by PBT within 30 days, 24 h (24HR-BT), or 24 h until 30 days (Postop...
Source
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.